$RGC Regencell conducted its second efficacy trial
Post# of 18238
(Total Views: 101)
Posted On: 09/19/2022 10:52:23 AM
$RGC Regencell conducted its second efficacy trial using standardized Traditional Chinese Medicine (“TCM”) formulae. “Our aim is to save and improve lives by making our standardized TCM formulae widely available to ADHD and ASD patients around the world. It is known that there is a significant economic impact and increased parental burden to families that care for children with ADHD and ASD. These positive data from the second efficacy trial bring us one step closer to improving the conditions and quality of life of patients and reducing the negative impact that ADHD and ASD have on patients and their families,” said Yat-Gai Au, founder and CEO of Regencell. https://www.businesswire.com/news/home/202209...cacy-Trial
(0)
(0)
Scroll down for more posts ▼